Pharmacologic Inhibition of MEK–ERK Signaling Enhances Th17 Differentiation

Andy Hee‐Meng Tan(Bioprocessing Technology Institute), Kong‐Peng Lam(Agency for Science, Technology and Research)

The Journal of Immunology

January 8, 2010

10.4049/jimmunol.0901509

Cited by 49

Related Papers

Dok-3 plays a nonredundant role in negative regulation of B-cell activation

|Blood|2007|47

Dok3–protein phosphatase 1 interaction attenuates Card9 signaling and neutrophil-dependent antifungal immunity

|Journal of Clinical Investigation|2019|43

Leupaxin Negatively Regulates B Cell Receptor Signaling

|Journal of Biological Chemistry|2007|30

Combined deficiencies in Bruton tyrosine kinase and phospholipase Cγ2 arrest B-cell development at a pre-BCR+ stage

|Blood|2006|26

An Inhibitory Role for Human CD96 Endodomain in T Cell Anti-Tumor Responses

|Cells|2023|9